Evidence map›Paper›PMID 27485686›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety.

Erica Y Shen, Yan Jiang, Behnam Javidfar, Bibi Kassim, Yong-Hwee E Loh, Qi Ma, Amanda C Mitchell, Venu Pothula, A Francis Stewart, Patricia Ernst and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. tRNA epitranscriptomic alterations associated with opioid-induced reward-seeking and long-term opioid withdrawal in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Critical periods and Autism Spectrum Disorders, a role for sleep.Neurobiology of sleep and circadian rhythms · 2023
    Article
  19. Article
  20. Genes · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Erica Y ShenDepartment of Psychiatry, New York, NY, USA.
Yan JiangDepartment of Psychiatry, New York, NY, USA.
Behnam JavidfarDepartment of Psychiatry, New York, NY, USA.
Bibi KassimDepartment of Psychiatry, New York, NY, USA.
Yong-Hwee E LohDepartment of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY, USA.
Qi MaBrudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Amanda C MitchellDepartment of Psychiatry, New York, NY, USA.
Venu PothulaDepartment of Psychiatry, New York, NY, USA.
A Francis StewartBiotechnology Center, Technische Universitaet, Dresden, Germany.
Patricia ErnstUniversity of Colorado School of Medicine, Department of Pediatrics, Aurora, CO, USA.
Wei-Dong YaoDepartment of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.
Gilles MartinBrudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA, USA.
Li ShenDepartment of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, NY, USA.ORCID 0000-0002-5190-2851
Mira JakovcevskiDepartment of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany.
Schahram AkbarianDepartment of Psychiatry, New York, NY, USA.
New York Proton Center · USAllen Institute for Brain Science · USUniversity of Massachusetts Chan Medical School · USMax Planck Institute of Psychiatry · DESUNY Upstate Medical University · USTechnische Universität Dresden · DEUniversity of Colorado Denver · US

Funding

New England Primate Research Center Base GrantP51OD011103 · OD · HARVARD MEDICAL SCHOOL · PI FLIER, JEFFREY S · 2012 to 2013
$24.7M
REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAMMINGA, CAROL A · 2012 to 2021
$20.2M
Neurodevelopmental Phenotypes in MLL mutant miceR01MH104341 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AKBARIAN, SCHAHRAM · 2015 to 2019
$2.1M
Remodeling Neuronal Chromatin in Mouse Models for DepressionR01MH086509 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AKBARIAN, SCHAHRAM · 2010 to 2014
$2.0M
Dopaminergic Enabling of Synaptic Plasticity in Prefrontal CircuitsR01DA032283 · NIDA · UPSTATE MEDICAL UNIVERSITY · PI YAO, WEI-DONG · 2011 to 2015
$1.7M
NIDA NIH HHS R01 DA032283NIH HHS P51 OD011103NIMH NIH HHS P50 MH096890NIMH NIH HHS R01 MH086509NIMH NIH HHS R01 MH104341
6 · The paper itself

Abstract

Lysine (K) methyltransferase 2a (Kmt2a) and other regulators of H3 lysine 4 methylation, a histone modification enriched at promoters and enhancers, are widely expressed throughout the brain, but molecular and cellular phenotypes in subcortical areas remain poorly explored. We report that Kmt2a conditional deletion in postnatal forebrain is associated with excessive nocturnal activity and with absent or blunted responses to stimulant and dopaminergic agonist drugs, in conjunction with near-complete loss of spike-timing-dependent long-term potentiation in medium spiny neurons (MSNs). Selective ablation of Kmt2a, but not the ortholog Kmt2b, in adult ventral striatum/nucleus accumbens neurons markedly increased anxiety scores in multiple behavioral paradigms. Striatal transcriptome sequencing in adult mutants identified 262 Kmt2a-sensitive genes, mostly downregulated in Kmt2a-deficient mice. Transcriptional repression includes the 5-Htr2a serotonin receptor, strongly associated with anxiety- and depression-related disorders in human and animal models. Consistent with the role of Kmt2a in promoting gene expression, the transcriptional regulators Bahcc1, Isl1, and Sp9 were downregulated and affected by H3K4 promoter hypomethylation. Therefore, Kmt2a regulates synaptic plasticity in striatal neurons and provides an epigenetic drug target for anxiety and dopamine-mediated behaviors.

Indexed as

AnxietyAction PotentialsAnimalsAnimals, NewbornCircadian RhythmDisease Models, AnimalDopamine AgentsFemaleHistone-Lysine N-MethyltransferaseLocomotionMaleMiceMice, Inbred C57BLMice, KnockoutMyeloid-Lymphoid Leukemia ProteinNerve Tissue ProteinsDopamine AgentsHistone-Lysine N-MethyltransferaseKmt2a protein, mouseMyeloid-Lymphoid Leukemia ProteinNerve Tissue Proteins

Identifiers

PMID27485686
PMCPMC5101561
OpenAlexW2490663973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.